New Model of Action for Mood Stabilizers: Phosphoproteome from Rat Pre-Frontal Cortex Synaptoneurosomal Preparations

• Maria Corena-McLeod ,

  * E-mail: pilarcorena@gmail.com

  Affiliation Neuropsycopharmacology Laboratory, Mayo Clinic, Jacksonville, Florida, United States of America

  ⨯
• Consuelo Walss-Bass,

  Affiliation Department of Psychiatry, University of Texas Health Science Center, San Antonio, Texas, United States of America

  ⨯
• Alfredo Oliveros,

  Affiliation Neuropsycopharmacology Laboratory, Mayo Clinic, Jacksonville, Florida, United States of America

  ⨯
• Andres Gordillo Villegas,

  Affiliation College of Medicine, Health Science Center, Department of Medicine, Division of Hematology/Oncology, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Carolina Ceballos,

  Affiliation Center for Translational Research in Neurodegenerative Diseases, University of Florida, Gainesville, Florida, United States of America

  ⨯
• Cristine M. Charlesworth,

  Affiliation Mayo Proteomics Research Center, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Benjamin Madden,

  Affiliation Mayo Proteomics Research Center, Mayo Clinic, Rochester, Minnesota, United States of America

  ⨯
• Paul J. Linser,

  Affiliation The Whitney Laboratory for Marine Bioscience, University of Florida, St. Augustine, Florida, United States of America

  ⨯
• Leslie Van Ekeris,

  Affiliation The Whitney Laboratory for Marine Bioscience, University of Florida, St. Augustine, Florida, United States of America

  ⨯
• Kristin Smith,

  Affiliation Cancer Biology, Mayo Clinic, Jacksonville, Florida, United States of America

  ⨯
• Elliott Richelson

  Affiliation Neuropsycopharmacology Laboratory, Mayo Clinic, Jacksonville, Florida, United States of America

  ⨯